Driehaus Capital Management LLC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 938206 Chicago, IL

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$45,928,826

+$16,490,013 QoQ

Shares Held

718,199

+17.5% QoQ

Ownership

0.460%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#13

of 266 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 78% Shared 0% None 22%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $285,823,124 across 6 Drug Manufacturers - Specialty & Generic names. KNSA ranks #4 (16.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	2,299,054	$94,330,185
2	ALKS	Alkermes plc.	1,238,809	$64,913,591
3	AMLX	Amylyx Pharmaceuticals, Inc.	3,036,970	$54,543,981
4	KNSA	Kiniksa Pharmaceuticals International, plc This page	718,199	$45,928,826
5	ELAN	Elanco Animal Health Inc	650,940	$16,019,633
6	ANIP	Ani Pharmaceuticals Inc	121,852	$10,086,908

All Filings in KNSA

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,928,826	718,199	+17.5%	Shares	Sole	2026-08-14
2026-03-31	$29,438,813	611,398	-3.4%	Shares	Sole	2026-05-15
2025-12-31	$26,104,113	632,827	-3.3%	Shares	Sole	2026-02-17
2025-09-30	$25,417,535	654,585	+1.0%	Shares	Sole	2025-11-14
2025-06-30	$17,929,606	647,980	+6.0%	Shares	Sole	2025-08-14
2025-03-31	$13,576,484	611,278	-0.4%	Shares	Sole	2025-05-15
2024-12-31	$12,136,019	613,550	-16.1%	Shares	Sole	2025-02-14
2024-09-30	$18,266,265	730,943	+18.7%	Shares	Sole	2024-11-14
2024-06-30	$11,497,658	615,836	—	Shares	Sole	2024-08-15
No filing history on record for this holder in this stock.